Jazz Pharmaceuticals announces offering of $500 million of 1.50% exchangeable senior notes
Jazz Pharmaceuticals announced an offering of $500 million of 1.50% exchangeable senior notes due 2024 in a private offering to qualified institutional buyers. The Issuer has also granted initial purchasers of the notes a 13-day option to purchase up to an additional $75 million of notes. August 18, 2017